Optimizing Treatment Effects on OSA-related Clinical and Patient-centered Outcomes Among Blacks

NYU Langone Health

Overview

The study is to maximize efficacy of message delivery to achieve desired Obstructive sleep apnea (OSA) adherence goal. Newly diagnosed black patients (n=390, all genders) from participating sleep clinics will be randomly exposed to either the individually tailored or standard OSA messages. Investigators will look at an effective and scalable intervention to improve OSA-related outcomes: a) clinical CVD and brain health measures and b) patient-centered outcomes. Patient-centered and adherence data will be captured via REDCap, enabling real-time application of data-driven decision rules while implementing the intervention.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Conditions

Obstructive Sleep Apnea

Interventions

Tailored VideosBEHAVIORAL

web-based OSA messages (videos featuring role models and coaching advice using motivational enhancement) addressing OSA barriers within a health literacy framework--to decrease cognitive load and render messages understandable and actionable. OSA messages were tailored based on focus group data in the previous study (group tailoring).

OSA TreatmentBEHAVIORAL

Web-based platform delivering messages promoting OSA self-efficacy. . All patients will view the introductory video, followed by the video cluster: Sleep, Health, and Well-Being; Sleep-Heart Health; Lifestyle Changes; and Sleep Hygiene.

Standard VideosBEHAVIORAL

Patients in the control arm will also receive an iPad, providing access to standard online OSA health information (e.g., National Sleep Foundation) in an equivalent dose as in the intervention arm using pre-selected automatic alerts to access the website

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Self-reported race/ethnicity as African American, African, Caribbean or black * Accessible by phone * No plans to move away within the year * OSA diagnosis, consent, including permission to release medical data * Physician-diagnosed medical conditions. Exclusion Criteria: * Progressive illnesses in which disability or death is expected within 1 year * Impaired cognitive/ functional ability precluding participation * Intention to move within the same year of enrollment * Family member currently enrolled

Locations (1)

New York University School of Medicine

New York, New York, United States

Outcomes

Primary Outcomes

Change from Baseline OSA Self-Efficacy Scale Score to 6 Months Score

The mean of the nonmissing item responses was calculated for each of the 3 subscales: Perceived Risk, Outcome Expectancies, and Treatment Self-Efficacy. Using this mean-weighted score prevents the distortion of the score from missing responses. Factor 1 (Risk Perception consisting of 8 questions); Factor 2 (Outcome Expectancy consisting of 9 items) and Factor 3 (Treatment Self Efficacy consisting of 9 items) are given a potential score of 1-4.

Time frame: 2 Months and 6 Months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.